Renaissance Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.7M | Sell |
4,354
-280
| -6% | -$118K | 0.07% | 139 |
|
|
2026
Q1 | $2.19M | Sell |
4,634
-1,480
| -24% | -$745K | 0.09% | 134 |
|
|
2025
Q4 | $2.85M | Sell |
6,114
-220
| -3% | -$102K | 0.11% | 133 |
|
|
2025
Q3 | $2.7M | Sell |
6,334
-85,712
| -93% | -$33.2M | 0.1% | 132 |
|
|
2025
Q2 | $35.3M | Sell |
92,046
-3,197
| -3% | -$1.15M | 1.37% | 30 |
|
|
2025
Q1 | $32.9M | Buy |
95,243
+2,598
| +3% | +$836K | 1.45% | 26 |
|
|
2024
Q4 | $27.8M | Buy |
92,645
+3,607
| +4% | +$1.26M | 1.15% | 48 |
|
|
2024
Q3 | $36.2M | Sell |
89,038
-13,446
| -13% | -$4.92M | 1.49% | 18 |
|
|
2024
Q2 | $32.9M | Sell |
102,484
-6,964
| -6% | -$2.26M | 1.28% | 32 |
|
|
2024
Q1 | $36.5M | Sell |
109,448
-2,869
| -3% | -$877K | 1.38% | 25 |
|
|
2023
Q4 | $30.4M | Buy |
112,317
+1,303
| +1% | +$322K | 1.26% | 39 |
|
|
2023
Q3 | $27.3M | Sell |
111,014
-449
| -0.4% | -$123K | 1.25% | 43 |
|
|
2023
Q2 | $33.8M | Sell |
111,463
-16,608
| -13% | -$4.62M | 1.46% | 15 |
|
|
2023
Q1 | $33.8M | Sell |
128,071
-4,498
| -3% | -$1.14M | 1.55% | 5 |
|
|
2022
Q4 | $31.8M | Sell |
132,569
-3,453
| -3% | -$773K | 1.56% | 4 |
|
|
2022
Q3 | $25M | Buy |
136,022
+10,321
| +8% | +$2.06M | 1.34% | 30 |
|
|
2022
Q2 | $21.1M | Buy |
125,701
+2,093
| +2% | +$450K | 1.09% | 51 |
|
|
2022
Q1 | $31M | Sell |
123,608
-2,658
| -2% | -$667K | 1.39% | 20 |
|
|
2021
Q4 | $32.4M | Sell |
126,266
-1,944
| -2% | -$476K | 1.32% | 33 |
|
|
2021
Q3 | $31.1M | Sell |
128,210
-24,234
| -16% | -$5.92M | 1.34% | 24 |
|
|
2021
Q2 | $31.5M | Sell |
152,444
-45,491
| -23% | -$9.27M | 1.32% | 24 |
|
|
2021
Q1 | $37.3M | Sell |
197,935
-14,244
| -7% | -$2.51M | 1.58% | 2 |
|
|
2020
Q4 | $34.9M | Sell |
212,179
-18,454
| -8% | -$2.7M | 1.5% | 6 |
|
|
2020
Q3 | $28.8M | Sell |
230,633
-2,245
| -1% | -$278K | 1.33% | 25 |
|
|
2020
Q2 | $22.6M | Buy |
232,878
+34,506
| +17% | +$3.59M | 1.08% | 50 |
|
|
2020
Q1 | $17.8M | Sell |
198,372
-6,141
| -3% | -$795K | 0.99% | 53 |
|
|
2019
Q4 | $30.2M | Sell |
204,513
-6,707
| -3% | -$901K | 1.24% | 16 |
|
|
2019
Q3 | $25.4M | Buy |
211,220
+8,431
| +4% | +$1.09M | 1.08% | 46 |
|
|
2019
Q2 | $27.4M | Sell |
202,789
-1,554
| -0.8% | -$196K | 1.11% | 34 |
|
|
2019
Q1 | $26.6M | Buy |
+204,343
| New | +$27.4M | 1.06% | 37 |
|
Other funds holding HCA
Renaissance Group's HCA Position: Q2 2026 in Review
Renaissance Group reduced its HCA Healthcare (HCA) stake by 6% in Q2 2026, selling an estimated $118K and leaving 4,354 shares worth $1.7M. The position accounts for 0.07% of the portfolio, ranked #139.
Renaissance Group first reported a position in HCA in Q1 2019 and has held it in 30 quarters since. The position peaked at $37.3M in Q1 2021. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Renaissance Group held 4,354 shares of HCA Healthcare worth $1.7M as of Q2 2026.
- Renaissance Group sold 280 HCA Healthcare shares in Q2 2026, an estimated $118K.
- HCA Healthcare made up 0.07% of Renaissance Group's portfolio in Q2 2026, its #139 holding.
- Renaissance Group first reported a position in HCA Healthcare in Q1 2019 and has held it in 30 quarters since.
- Renaissance Group's HCA Healthcare position peaked at $37.3M in Q1 2021.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.